1025-028X

S1025-028X2021000300145

Pakistan

00 12 2021

30 3 145 152

2020 14 5 5

1361-76

2020 18

222

2004 101 17 17

6641-6

2020 11

589833

2020 382 21 21

1969-73

2020 19 5 5

305-6

2020 22 4 4

10-5

2020 1939 12 12

2021 21 4 4

465-6

2017 543 7644 7644

248-51

2020 368 6494 6494

945-6

2020

World Health Organization 2020

Coalition for Epidemic Preparedness Innovations 2020

2021 27 2 2

205-11

2020

2020 11

298

2016 7 3 3

155-65

World Health Organization 2020

2021 372

296

2015 479-480

379-92

2015 7 301 301

301ra132

2014 2 3 3

624-41

2021 8

635337

2020 395

1845-54

2020 396

479-88

2021 95 7 7

e02260-20

Clinicaltrials.gov

2020

2021 397

671-81

2020 163 4 4

682-94

Chinese Clinical Trial Registry 2020

2021 1 1 1

43-51

Li J mRNA vaccines: possible tools to combat SARS-CoV-2 2020 35 3 3

259-62

Weissman D mRNA vaccines-a new era in vaccinology 2018 17 4 4

261-79

2021 384 5 5

403-16

Food and Drug Administration US 2020

2020 383 16 16

1544-55

2019 10

594

2020 3 2 2

World Health Organization 2020

Food and Drug Administration 2021

2018 19 11 11

3605

2020 11 1 1

2601

SAGE Working Group on Vaccine Hesitancy 2015 33 34 34

4161-4

2021 9 1 1

World Health Organization/Europe 2017

2021 43 2 2

e291-2

2019 394

915-6

2021 94

41-50

2015 10 9 9

2018 37 4 4

307-15

2020 9 1 1

2020 396

898-908

2020 16 9 9

2204-14

2021 27 2 2

225-8

2020 182 5 5

1271-83

2020 8

381

2020 21

977-82

2021 25 5 5

331-3

2020 37